[Testicular Cancer: Diagnostics, Therapy and Follow Up]

Praxis (Bern 1994). 2016 May 25;105(11):643-8. doi: 10.1024/1661-8157/a002364.
[Article in German]

Abstract

Germ cell tumours represent a rare malignancy that affects mostly young men between 15 and 40 years of age. In approximately 50 % of the cases pure seminoma is found, 50 % non-seminomas are divided into hetrogenous subgroups. The initial therapeutic step usually is orchiectomy, further procedures are defined by histology, clinical staging and risk profile.Therpeutical options consist in active surveillance, radiotherapy or chemotherapy. Stage I shows a cure rate of almost 100 %but even in metastatic stages more then 80 % of all patients can be cured. However they must remain in a close longterm followup during which especially cardiovascular risk factors have to be monitored.

Keywords: Chemotherapie; Hodenkarzinom; Nachsorge; Tumormarker; cancer des testicules; chemotherapy; chimiothérapie; follow up; marqueurs tumoraux; serum tumor markers; suivi des patients; surveillance; testicular cancer; Überwachung.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers, Tumor / blood
  • Combined Modality Therapy
  • Follow-Up Studies
  • Humans
  • Male
  • Neoplasm Staging
  • Neoplasms, Germ Cell and Embryonal / diagnosis
  • Neoplasms, Germ Cell and Embryonal / pathology
  • Neoplasms, Germ Cell and Embryonal / therapy*
  • Orchiectomy
  • Prognosis
  • Seminoma / diagnosis
  • Seminoma / pathology
  • Seminoma / therapy
  • Testicular Neoplasms / diagnosis
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / therapy*
  • Young Adult

Substances

  • Biomarkers, Tumor

Supplementary concepts

  • Nonseminomatous germ cell tumor